Tune Therapeutics

Updated: September 14, 2025
CEO - John McHutchison
CEO - John McHutchison
Country: USA | Funding: $215M (+)

Website: https://tunetx.com/

Tune Therapeutics develops epigenomic controls that dial gene expression up or down to potentially thwart cancers, genetic diseases and aging.

Competitors